Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pharmacyte Biotech Inc (PMCB)

Pharmacyte Biotech Inc (PMCB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 45,759
  • Shares Outstanding, K 1,361,871
  • Annual Sales, $ 0 K
  • Annual Income, $ -4,070 K
  • 60-Month Beta 2.08
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 12/13/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0323 +5.88%
on 12/05/19
0.0372 -8.06%
on 11/20/19
-0.0009 (-2.56%)
since 11/05/19
3-Month
0.0319 +7.21%
on 10/16/19
0.0395 -13.42%
on 09/23/19
-0.0013 (-3.66%)
since 09/05/19
52-Week
0.0319 +7.21%
on 10/16/19
0.0678 -49.56%
on 02/05/19
-0.0128 (-27.23%)
since 12/04/18

Most Recent Stories

More News
PharmaCyte Biotech "Release Testing" Successful on All Completed Tests of Clinical Trial Product

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box(R),...

PMCB : 0.0342 (+1.79%)
PharmaCyte Biotech Successfully Completes Final Manufacturing Run of Clinical Trial Product

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box(R),...

PMCB : 0.0342 (+1.79%)
PharmaCyte Biotech's "Release Testing" Last Critical Event Before Submission of Investigational New Drug Application

PharmaCyte Biotech (OTCQB: PMCB) has reduced a long list of FDA-required items to just one last important component--release testing--before it can submit an Investigational New Drug application (IND)...

PMCB : 0.0342 (+1.79%)
PharmaCyte Biotech Closer to Submitting IND by Successfully Completing Encapsulation of Second Manufacturing Run of Clinical Trial Product

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box(R),...

PMCB : 0.0342 (+1.79%)
PharmaCyte Biotech to Change Future of Treating Diseases with Validation of Encapsulation Technology in Pancreatic Cancer Trial

PharmaCyte Biotech (OTCQB: PMCB) has a technology that could very well change the way a host of hard-to-treat diseases are treated for the foreseeable future. The company is closer than ever to its upcoming...

PMCB : 0.0342 (+1.79%)
PharmaCyte Biotech Closer to Submitting IND with Successful Completion of Clinical Trial Product

PharmaCyte Biotech (OTCQB: PMCB) has now moved one step closer to submitting an Investigational New Drug application (IND) to the U.S. Food and Drug Administration (FDA) to request a clinical trial in...

PMCB : 0.0342 (+1.79%)
PharmaCyte Biotech Successfully Completes Manufacturing of Clinical Trial Product

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box(R),...

PMCB : 0.0342 (+1.79%)
PharmaCyte Biotech Q&A Discussion with Cellular Biologist David A. Judd

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box(R),...

PMCB : 0.0342 (+1.79%)
PharmaCyte Biotech Releases Shareholder Update Call Playback Information

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box(R),...

PMCB : 0.0342 (+1.79%)
PharmaCyte Biotech's Pancreatic Cancer Therapy Production in Final Days of Key Manufacturing Run

PharmaCyte Biotech (OTCQB: PMCB) and its partner, Austrianova, along with the company's cellular biologist, David Judd, are all more confident than ever that they have a product that can succeed in a U.S....

PMCB : 0.0342 (+1.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade PMCB with:

Key Turning Points

2nd Resistance Point 0.0355
1st Resistance Point 0.0348
Last Price 0.0342
1st Support Level 0.0329
2nd Support Level 0.0317

See More

52-Week High 0.0678
Fibonacci 61.8% 0.0541
Fibonacci 50% 0.0499
Fibonacci 38.2% 0.0456
Last Price 0.0342
52-Week Low 0.0319

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar